Belluscura stock plummets by 50% after nixing annual forecast amid Trump tariffs
Belluscura’s stock price has crashed by almost 50% after announcing plans to scrap its 2025 guidance due to uncertainty stoked by the Trump administration’s imposition of 54% tariffs on goods imported from China. The post Belluscura stock plummets by 50% after nixing annual forecast amid Trump tariffs appeared first on Medical Device Network.
Belluscura’s stock price has crashed by almost 50% after announcing plans to scrap its 2025 guidance due to uncertainty stoked by the Trump administration’s imposition of 54% tariffs on goods imported from China.
The post Belluscura stock plummets by 50% after nixing annual forecast amid Trump tariffs appeared first on Medical Device Network.
